Novel agents in colorectal cancer.
Erlichman
C
C
Mayo Clinic, Rochester, Minnesota, USA.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D004273:DNA, Neoplasm / Q000187:drug effects; D015507:Drugs, Investigational / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D015398:Signal Transduction / Q000187:drug effects
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D015507:Drugs, Investigational; D004791:Enzyme Inhibitors